ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
생체 동일 호르몬 시장 규모는 앞으로 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 5.9%를 나타낼 것으로 예측되고 100억 2,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 여성 건강에 주력하는 경향, 맞춤형 의약품의 수용 확대, 정부 지원 정책, 만성 질환 유병률 증가, 생체동일성 호르몬의 이점에 대한 인식 제고 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 새로운 생체동일성 호르몬 제형 개발, 호르몬 치료 상담을 위한 원격의료 활용 증가, 주류 의학 내 생체동일성 호르몬 통합 확대, 호르몬 전달 시스템 발전, 호르몬 생산에서 바이오테크놀로지의 역할 확대 등이 포함됩니다.
향후 5년간 5.9% 성장 전망은 이 시장에 대한 이전 추정치 대비 0.4% 소폭 하향 조정된 수치입니다. 이러한 하향 조정은 주로 미국과 타국 간 관세 영향에 기인합니다. 관세 부과로 인해 벨기에 및 호주에서 수입되는 복합 호르몬 제제와 경피 전달 시스템의 접근성이 제한될 수 있어, 미국 내분비학 분야에 상당한 도전이 될 수 있습니다. 이는 갱년기 관리 악화와 전문 약국 비용 증가로 이어질 가능성이 있습니다. 또한 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 파급 효과는 더욱 광범위해질 것입니다.
춤형 의약품에 대한 수요 증가는 생체동등 호르몬 시장 성장을 촉진할 것으로 예상됩니다. 맞춤형 의약품은 유전적 특성이나 생활습관 등 개인 특성에 기반해 치료법을 맞춤화하여 효과성을 향상시키고 부작용을 감축하는 접근법입니다. 이러한 수요 증가는 더 효과적인 치료 제공 가능성, 유전체학 발전, 질병 복잡성 증가, 규제 지원 등에서 기인합니다. 생체동등 호르몬은 환자의 특정 호르몬 프로필에 맞춰 치료 효능을 개선하고 부작용을 최소화함으로써 맞춤형 의약품과 부합합니다. 예를 들어, 2024년 2월 맞춤형 의학 연합(Personalized Medicine Coalition)은 FDA가 2023년에 희귀 질환을 위한 16개의 새로운 맞춤형 치료법을 승인했으며, 이는 2022년의 6개에서 증가한 수치라고 보고했습니다. 따라서 맞춤형 의약품에 대한 수요 증가는 생체동등 호르몬 시장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 생체 동일 호르몬 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 생체 동일 호르몬 시장 : 성장률 분석
세계의 생체 동일 호르몬 시장 실적 : 규모와 성장(2019-2024년)
세계의 생체 동일 호르몬 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 생체 동일 호르몬 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 생체 동일 호르몬 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
에스트로겐
프로게스테론
테스토스테론
기타 유형
세계의 생체 동일 호르몬 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정제 및 캡슐
크림과 젤
패치와 임플란트
주사제
기타 제품 유형
세계의 생체 동일 호르몬 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 생체 동일 호르몬 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
갱년기 장애 관리
호르몬 보충 요법(HRT)
갑상선 질환
남성 갱년기 장애 관리
세계의 생체 동일 호르몬 시장 : 최종 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
부인과 클리닉
연구실
기타 최종 사용자
세계의 생체 동일 호르몬 시장, 에스트로겐 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
에스트론(E1)
에스트라디올(E2)
에스트리올(E3)
생체 동일 에스트라디올 크림
생체 동일 에스트론 크림
세계의 생체 동일 호르몬 시장, 프로게스테론 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
생체 동일 프로게스테론 크림
생체 동일 프로게스테론 캡슐
생체 동일 프로게스테론 주사
세계의 생체 동일 호르몬 시장, 테스토스테론 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
생체 동일 테스토스테론 크림
생체 동일 테스토스테론 주사
생체 동일 테스토스테론 펠렛
생체 동일 테스토스테론 젤
세계의 생체 동일 호르몬 시장, 기타 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
Dhea(데히드로에피안드로스테론)
갑상선 호르몬(T3, T4)
코르티솔
멜라토닌
인간 성장 호르몬(HGH)
제7장 지역별 및 국가별 분석
세계의 생체 동일 호르몬 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 생체 동일 호르몬 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
생체 동일 호르몬 시장 : 경쟁 구도
생체 동일 호르몬 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Hikma Pharmaceuticals Plc
TherapeuticsMD Inc.
Gedeon Richter Plc
Noven Pharmaceuticals Inc.
AnazaoHealth Corp.
Women's International Pharmacy Inc.
Wells Pharmacy Network
ZRT Laboratory LLC
BionPharma Inc.
Orion Pharma AB
Actiza Pharmaceutical Private Limited
Biostation
Advantage Pharmaceuticals Inc.
Bravado Labs
Neuva Aesthetics
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
생체 동일 호르몬 시장(2029년) : 새로운 기회를 제공하는 국가
생체 동일 호르몬 시장(2029년) : 새로운 기회를 제공하는 부문
생체 동일 호르몬 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Bioidentical hormones are identical in chemical structure to those naturally produced by the human body, often used in hormone replacement therapy to address imbalances. They are particularly effective in easing symptoms associated with menopause, andropause, and other hormonal deficiencies, such as hot flashes, night sweats, mood swings, and low libido.
The primary bioidentical hormones include estrogen, progesterone, testosterone, and others. Estrogen, a key female sex hormone, regulates reproductive and secondary sexual characteristics. These hormones are available in various forms such as tablets, capsules, creams, gels, patches, implants, and injectables. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. Applications for bioidentical hormones include managing menopause, hormone replacement therapy (HRT), thyroid disorders, and andropause. They are utilized by diverse end-users such as hospitals, gynecology clinics, research laboratories, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The bioidentical hormones market research report is one of a series of new reports from The Business Research Company that provides bioidentical hormones market statistics, including bioidentical hormones industry global market size, regional shares, competitors with a bioidentical hormones market share, detailed bioidentical hormones market segments, market trends and opportunities, and any further data you may need to thrive in the bioidentical hormones industry. This bioidentical hormones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioidentical hormones market size has grown strongly in recent years. It will grow from $7.49 billion in 2024 to $7.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to a rise in awareness of hormone-related health issues, increased prevalence of hormonal imbalances, increased aging population, increased healthcare expenditure, and increased demand for alternative medicine.
The bioidentical hormones market size is expected to see strong growth in the next few years. It will grow to $10.02 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing focus on women's health, growing acceptance of personalized medicine, supportive government policies, increasing prevalence of chronic diseases, and rising awareness of the benefits of bioidentical hormones. Major trends in the forecast period include the development of novel bioidentical hormone formulations, growing use of telemedicine for hormone therapy consultations, increasing integration of bioidentical hormones in mainstream medicine, advancements in hormone delivery systems, and the expanding role of biotechnology in hormone production.
The forecast of 5.9% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. endocrinology by restricting access to compounded hormone formulations and transdermal delivery systems imported from Belgium and Australia, potentially worsening menopause management and increasing specialty pharmacy costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing demand for personalized medicine is anticipated to drive the growth of the bioidentical hormones market. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetics or lifestyle, to enhance effectiveness and reduce adverse effects. This growing demand stems from its potential to offer more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. Bioidentical hormones align with personalized medicine by matching a patient's specific hormonal profile, improving treatment efficacy, and minimizing side effects. For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. Thus, the rising demand for personalized medicine is fueling the bioidentical hormones market.
Leading companies in the bioidentical hormones market are focusing on developing advanced solutions such as bioidentical hormone replacement therapy (BHRT) to provide more effective and personalized treatments for hormonal imbalances and related health conditions. BHRT uses hormones that are chemically identical to those produced by the human body to address hormone imbalances and associated symptoms. For example, in May 2024, Jagsonpal Pharmaceuticals Limited, an Indian pharmaceutical company, launched MemUp HRT, a US FDA-approved bioidentical hormone therapy. This therapy features a single-pill solution combining bioidentical estradiol and progesterone, with support available in nine regional languages. This launch aims to leverage bioidentical hormones for balanced hormone replacement and improve patient compliance, thereby raising awareness about menopause management, enhancing patient outcomes, and expanding healthcare options for women in India.
In January 2024, BioTE Medical, LLC, a US-based healthcare company, acquired Asteria Health for $8.5 million. This acquisition strengthens BioTE's supply chain, enhances manufacturing capabilities, and improves its margin profile, positioning BioTE as a vertically integrated leader in the bioidentical hormones market and ensuring reliable access to innovative therapeutic wellness solutions. Asteria Health, based in the UK, provides pharmaceutical compounding solutions, including compounded bioidentical hormones.
North America was the largest region in the bioidentical hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioidentical hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioidentical hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bioidentical hormones market includes revenues earned by entities by providing services such as personalized hormone level testing, compounding pharmacy services, anti-aging treatments, wellness and longevity programs, weight management support, and integrative health services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioidentical Hormones Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bioidentical hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bioidentical hormones ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioidentical hormones market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Estrogen; Progesterone; Testosterone; Other Types
2) By Product Type: Tablet And Capsule; Cream And Gel; Patch And Implant; Injectable; Other Product Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bioidentical Hormones Market Characteristics
3. Bioidentical Hormones Market Trends And Strategies
4. Bioidentical Hormones Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Bioidentical Hormones Growth Analysis And Strategic Analysis Framework
5.1. Global Bioidentical Hormones PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bioidentical Hormones Market Growth Rate Analysis
5.4. Global Bioidentical Hormones Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bioidentical Hormones Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bioidentical Hormones Total Addressable Market (TAM)
6. Bioidentical Hormones Market Segmentation
6.1. Global Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrogen
Progesterone
Testosterone
Other Types
6.2. Global Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablet And Capsule
Cream And Gel
Patch And Implant
Injectable
Other Product Types
6.3. Global Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Bioidentical Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Menopause Management
Hormone Replacement Therapy (HRT)
Thyroid Disorders
Andropause Management
6.5. Global Bioidentical Hormones Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Gynecology Clinics
Research Laboratories
Other End-Users
6.6. Global Bioidentical Hormones Market, Sub-Segmentation Of Estrogen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrone (E1)
Estradiol (E2)
Estriol (E3)
Bioidentical Estradiol Creams
Bioidentical Estrone Creams
6.7. Global Bioidentical Hormones Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioidentical Progesterone Creams
Bioidentical Progesterone Capsules
Bioidentical Progesterone Injections
6.8. Global Bioidentical Hormones Market, Sub-Segmentation Of Testosterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioidentical Testosterone Creams
Bioidentical Testosterone Injections
Bioidentical Testosterone Pellets
Bioidentical Testosterone Gels
6.9. Global Bioidentical Hormones Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dhea (Dehydroepiandrosterone)
Thyroid Hormones (T3, T4)
Cortisol
Melatonin
Human Growth Hormone (Hgh)
7. Bioidentical Hormones Market Regional And Country Analysis
7.1. Global Bioidentical Hormones Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bioidentical Hormones Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bioidentical Hormones Market
9.1. China Bioidentical Hormones Market Overview
9.2. China Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bioidentical Hormones Market
10.1. India Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bioidentical Hormones Market
11.1. Japan Bioidentical Hormones Market Overview
11.2. Japan Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bioidentical Hormones Market
12.1. Australia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bioidentical Hormones Market
13.1. Indonesia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bioidentical Hormones Market
14.1. South Korea Bioidentical Hormones Market Overview
14.2. South Korea Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bioidentical Hormones Market
15.1. Western Europe Bioidentical Hormones Market Overview
15.2. Western Europe Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bioidentical Hormones Market
16.1. UK Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bioidentical Hormones Market
17.1. Germany Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bioidentical Hormones Market
18.1. France Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bioidentical Hormones Market
19.1. Italy Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bioidentical Hormones Market
20.1. Spain Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bioidentical Hormones Market
21.1. Eastern Europe Bioidentical Hormones Market Overview
21.2. Eastern Europe Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bioidentical Hormones Market
22.1. Russia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bioidentical Hormones Market
23.1. North America Bioidentical Hormones Market Overview
23.2. North America Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bioidentical Hormones Market
24.1. USA Bioidentical Hormones Market Overview
24.2. USA Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
